What New Trials Suggest About Pain and Mobility May 11, 2026 Articles, Bone & Joint, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,346 views For many patients with obesity-related osteoarthritis, daily movement can feel like walking with a heavy backpack that never comes off
How GLP-1 Programs Work: Complete an online health questionnaire Consult with a licensed healthcare provider via video or messaging Receive a prescription if you qualify (typically BMI of 30+, or 27+ with weight-related conditions) Get medication delivered to your home or local pharmacy Access ongoing support through the platform Most telehealth GLP-1 programs offer either brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) or compounded versions of semaglutide and tirzepatide
L.WilkenfeldR
Gastric emptying slows dramatically under tirzepatide
Ozempic at 1 mg or greater dose has the FDA indication for this use
Retatrutide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide1 (GLP1) receptor agonist